Teva to buy Auspex for $101/share in cash

Adam Reynolds | Bloomberg | Getty Images. Health-care stocks haven't gotten the green light many expected from Hillary Clinton's election loss.

Drugmaker Teva (Tel Aviv Stock Exchange: TEVA-IL)Pharmaceuticals said it would buy Auspex (NASDAQ: ASPX)for $101 per share in cash, or $3.5 billion in equity value.

Teva said the deal would add a portfolio of drugs for the treatment of central nervous system disorders.

Auspex shares closed Friday at $70.91.




More From CNBC